Ypsomed Holding AG

Company Profile

• Business description

  Ypsomed, based in Burgdorf, Switzerland, develops and manufactures self-injection devices like pens, autoinjectors, and infusion systems for global pharma and biotech companies. The company shifted focus to business-to-business injection systems, divesting its diabetes care segment to supply device platforms to pharma partners.The company operates in a market driven by strong growth in biologics, biosimilars, patient self-administration, and GLP-1 therapies for obesity. To meet demand, Ypsomed has embarked on an ambitious capacity expansion program, with capital expenditure reaching approximately 50% of sales in recent years. This investment is partially derisked through customer co-financing, which aligns incentives and secures future volume commitments before launch.

• Contact

  Brunnmattstrasse 6
  Burgdorf3401
  CHE

  T: +41 344244111

  E: [email protected]

  https://www.ypsomed.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Medical Instruments & Supplies

  Fiscal Year End

  31 March 2027

  Employees

  2,099